NSRX Nasus Pharma Ltd.

$4.00

Nasus Pharma Ltd. (NSRX) SEC Filings

Everything NSRX has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

5 filings
Date Form Filing
6-K EXECUTIVE_CHANGE
6-K EARNINGS_RELEASE
6-K EXECUTIVE_CHANGE
6-K CAPITAL_RAISE
6-K OTHER

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.